• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News · June 23, 2022

Kent Imaging Recognized as Most Innovative Medical Imaging Technology Developer in Canada

handheld-kent-imaging

SnapshotNIR is enabling clinicians to drive better outcomes in wound care, limb preservation, and surgery, with its diagnostic-driven imaging technology. NEWS PROVIDED BY Kent Imaging Inc. June 21, …

News · March 29, 2022

Egg Medical hatches technology to shield health care workers from radiation

The Arden Hills company has landed $13 million in financing.  By Burl Gilyard Star Tribune MARCH 27, 2022 — 2:00PM A Twin Cities medtech startup, Egg Medical Inc., is building up sales of a new …

News · March 15, 2022

Egg Medical hatches $13M VC funding

March 4, 2022 By Annette Boyle Egg Medical Inc. secured a $13 million investment from TVM Capital Life Science to solve the Humpty-Dumpty problem that plagues interventional cardiology …

News · March 3, 2022

Egg Medical, Inc., Closes on $13 million Financing

Egg Medical, Inc., Closes on $13 million Financing Arden Hills, MN (March 3rd, 2022) — Egg Medical, Inc., a medical device company commercializing technologies to reduce scatter radiation exposure …

News · February 8, 2022

CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO

centogene

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 08, 2022 (GLOBE NEWSWIRE – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, …

News · February 1, 2022

CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board

centogene

Nomination adds significant expertise to support pharma partnerships and an impressive track record in value creation CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE …

News · February 1, 2022

CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan

centogene

Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and …

News · February 1, 2022

CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer

centogene

Dr. Andrin Oswald resigns as CEO due to prolonged medical leave; Kim Stratton elected as successor CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene …

News · January 18, 2022

TVM Capital Life Science promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner

Munich, Germany / Montreal, Canada - 12 January 2022 – TVM Life Science (“TVM”), a leading International Life Sciences Venture Capital firm, today announces the formal promotion of Dr. Sascha Berger …

News · January 13, 2022

Syndivia and TVM Capital Life Science Announce Creation of Auricula Biosciences to Develop Innovative Therapy for Patients with K-Ras mutant malignancies

laboratory

Luxembourg, January 13th, 2022 – TVM Life Science Innovation II SCSp announced the Fund's investment establishing Auricula Biosciences, Inc., a company based in Wilmington, Delaware, USA. Auricula …

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 30
  • Go to Next Page »

Primary Sidebar

Secondary Sidebar

Additional News

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

November 22, 2021

Kent Imaging – Setting A New Global Standard in Advanced Tissue Assessment

November 16, 2021

Nekonal and TVM Capital Life Science Announce Creation of T7 Therapeutics to Develop Innovative Therapy for Patients with Auto-immune diseases

November 16, 2021

CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

October 8, 2021

Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation

October 8, 2021

  • in

Copyright © 2022 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact